2 completed, 1 not yet recruiting, 1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Andersen Syndrome: new trials by email Literature Review of Andersen Syndrome trials Research Report on Andersen Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| N-of-1 in ATS and MEPPC Flecainide, Flecainide + beta-blocker - Andersen Tawil Syndrome, Multifocal Ectopic Purkinje-related Premature Contractions | Phase 2 | Not yet recruiting | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 10 | 2025-03-01 | 2025-01-29 |
| Baby Detect : Genomic Newborn Screening Congenital Adrenal Hyperplasia, Familial Hyperinsulinemic Hypoglycemia 1 | Completed | Centre Hospitalier Universitaire de Liege | 6824 | 2022-09-01 | 2025-08-12 | |
| Effect of Potassium and Acetazolamide on People With Andersen-Tawil Syndrome Potassium, Acetazolamide - Andersen-Tawil Syndrome | Phase 1 | Terminated | University of Rochester | 3 | 2008-12-01 | 2012-01-20 |
| Characteristics of Andersen-Tawil Syndrome Andersen-Tawil Syndrome, Andersen Syndrome | Completed | University of Rochester | 28 | 2007-11-01 | 2013-01-16 |
3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency (1) · 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency (1) · Acidemia, isovaleric (1) · Acyl-CoA Dehydrogenase Family, Member 9, Deficiency of (1) · Adrenal Hyperplasia, Congenital (1) · Adrenoleukodystrophy (1) · Anemia, Diamond-Blackfan (1) · Anemia, Sickle Cell (1) · Argininosuccinic Aciduria (1) · Aromatic amino acid decarboxylase deficiency (1) · Arrhythmias, Cardiac (1) · Aspartylglucosaminuria (1) · Ataxia with vitamin E deficiency (1) · Basal ganglia disease, biotin-responsive (1)
Cardiac Conduction System Disease (4) · Cardiovascular Abnormalities (4) · Cardiovascular Diseases (4) · Congenital Abnormalities (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Heart Defects, Congenital (4) · Heart Diseases (4) · Long QT Syndrome (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Arrhythmias, Cardiac (3) · Musculoskeletal Diseases (2) · Nervous System Diseases (2) · Neurologic Manifestations (2) · Abnormalities, Multiple (1)
Acetazolamide (1) · Adrenergic beta-Antagonists (1) · Flecainide (1) · Potassium (1)
University of Rochester (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Centre Hospitalier Universitaire de Liege (1)
United States (2) · Belgium (1) · Canada (1) · Italy (1) · United Kingdom (1)
Emma Ciafaloni, MD (1) · Laurent Servais (1) · Paul Twydell, DO (1) · Robert C. Griggs, MD (1)
U54NS059065 (1), U54RR019482 (1)